2016 Q4/Global Life Sciences


Summary

Full results


Rank Chg Organisation name Overall
1 +7 Taisho Pharmaceutical
7.5
2 +8 Galenica AG
7.4
3 +11 Abbott Uk
7.0
4 -3 Wockhardt
7.0
5 +1 Kyorin Holdings
6.9
6 +6 MediGene
6.8
7 +12 Nissan Chemical
6.8
8 -4 Julphar
6.7
9 +2 Meda Pharmaceuticals
6.7
10 +5 Biotecnol
6.7
11 +13 Actelion
6.5
12 +10 Mitsubishi Tanabe Pharma Europe Ltd
6.4
13 +15 Debiopharm
6.3
14 -1 Anika Therapeutics
6.3
15 +1 Abbott
6.2
16 -13 Yakult UK
6.2
17 -8 Mitsubishi Tanabe
6.0
18 +0 HG Capital Trust
6.0
19 -1 Baxter International
6.0
20 +9 EISAI UK
6.0
21 +4 Bavarian Nordic
6.0
22 +12 Ipsen UK
6.0
23 +159 ALK-Abello
6.0
24 +112 Lexicon Pharmaceuticals
6.0
25 +2 QLT
5.9
26 +172 MannKind Corporation
5.8
27 -22 Kaken Pharmaceutical
5.8
28 -5 Nippon Chemiphar
5.8
29 +41 Chugai - Pharma
5.7
30 +9 Gruenenthal
5.7
31 +1 EISAI
5.6
32 +16 Galderma
5.6
33 +80 ARIAD Pharmaceuticals
5.6
34 +2 Dainippon Sumitomo
5.5
35 -5 Pfizer UK
5.5
36 -5 Merz
5.5
37 +24 Takeda UK
5.4
38 +0 Toray Industries
5.4
39 -19 Genmab
5.4
40 +41 Bial Portela
5.3
41 +21 Sanofi UK
5.2
42 +13 Biotest
5.2
43 +6 Apotex
5.2
44 -9 United Therapeutics
5.2
45 +5 Asahi Kasei
5.2
46 +20 Servier UK
5.2
47 -6 Stallergenes UK
5.2
48 +15 The Medicines Co
5.2
49 -5 Vitrolife
5.1
50 +33 Acorda Therapeutics
5.1


Changes in rank are compared to 2016 Q3/Global Life Sciences. Since then, 1 site entered the survey and 54 sites could not be included in the rankings (5 more since last time). Build your own. Report statistics.